Navigation Links
Massachusetts Governor Deval L. Patrick Pays Visit to WuXi PharmaTech

SHANGHAI, China, Dec. 14 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), China's premier provider of pharmaceutical R&D outsourcing services announced today that Governor Deval L. Patrick of the Commonwealth of Massachusetts, accompanied by other members of Massachusetts China Partnership Official Delegation, paid a visit to the company on December 7 in Shanghai, China.

(Logo: )

Massachusetts China Partnership Official Delegation visitors included representatives from Massachusetts life science industry and academia such as Joshua Schafer Boger, Chief Executive Officer of Vertex Pharmaceuticals, and Jack Martin Wilson, President of University of Massachusetts.

Massachusetts is the U.S.'s epicenter for biotechnology, with over 300 biopharmaceutical companies located in the state. With the intellectual resources of leading universities and healthcare institutions, biotechnology has become one of the most important industries in Massachusetts.

During the meeting between the honorable guests and the management team of the company, Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech, gave Governor Patrick a brief introduction of the company and hoped for more collaboration opportunities between the two parties for continued expansion of the biopharmaceutical industry.

"I am here to encourage the collaboration that WuXi PharmaTech has with Massachusetts companies such as Vertex, and with enterprises everywhere that have the interest and ability to contribute to the future of healing," commented Governor Patrick in his address. "This collaboration has benefits for both Massachusetts and China, and for the future of health care all over the world. Working together, we will be stronger and more successful than we ever could be working apart."

The Governor added, "As in th

SOURCE WuXi PharmaTech
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
2. AG Mednet Selected By Massachusetts General Hospital to Transport 3D Post-Processing Images
3. 2007 Massachusetts Biotechnology Council MASS Opportunities Investment Conference Showcases Leading Growth Companies
4. Sigma-Aldrich Names Patrick Sullivan New VP of Research and Development for Research Biotech
5. WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday, September 6, 2007
6. WuXi PharmaTech Announces Second Quarter 2007 Results
7. WuXi PharmaTech (NYSE: WX) Wins Both Deloitte Technology Fast 50 China and Deloitte Technology Fast 500 Asia
8. WuXi PharmaTech (NYSE: WX) Ranked the 28th of Deloitte Technology Fast 50 China
Post Your Comments:
(Date:7/1/2015)... InferMed , s ... will augment ... s olutions suite   Elsevier , ... and services, announced today the acquisition of  InferMed , a ... company. InferMed,s Arezzo technology supports clinicians in choosing ...
(Date:7/1/2015)... CONNECTICUT (PRWEB) , ... July 01, 2015 , ... ... or sterilized to combat pathogen transmission. CTI’ new Medical Joysticks have an ... medical devices now have an operator control device that will increase healthcare worker ...
(Date:6/30/2015)... 1, 2015 R-Japan Co.,Ltd. obtained the license of ... Regenerative Medicine from the Ministry of Health, Labour and Welfare ... The fact that R- Japan ... auditing from Pharmaceuticals and Medical Devices Agency (PMDA) on May ... to provide stem cell manufacturing service to medical institutions. As ...
(Date:6/30/2015)... CALGARY , June 30, 2015 /PRNewswire/ - ... ("Shareholders") of common shares of Resverlogix have approved ... to Eastern Capital Limited of 5,600,000 units at ... Private Placement"), each unit being comprised of one ... for aggregate proceeds of approximately CAD$15 million; and ...
Breaking Biology Technology:Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 2Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 4Sanitized Medical Joysticks for a Safer and Healthier Work Environment 2R-Japan Obtained Autologous Stem Cell Manufacturing License from the Ministry of Health, Labour and Welfare 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3
... National Science Foundation (NSF) has selected a University of ... of NSF Innovation Corps awards. The I-Corps Awards recognize ... connects scientists to entrepreneurial resources. "The idea is ... property from the lab into the commercial world," said ...
... Nanoparticles of a substance can be counted and the size ... gas. But some nanoparticles tend to aggregate when the surrounding ... shown that it is possible to sort and count the ... are already used in many everyday products, such as sunscreen ...
... Mich., Oct. 11, 2011 New England Biolabs, Inc. ... signed a distribution agreement whereby NEB will distribute a ... the amplification of DNA from single cells or extremely ... Genome Amplification (WGA) Kit is the first product available ...
Cached Biology Technology:Penn team wins entrepreneurial innovation award 2How to count nanoparticles 2New England Biolabs and Rubicon Genomics Enter into Distribution Agreement for Single Cell Amplification Products 2
(Date:6/24/2015)... , June 24, 2015 Biometry ... with emerging biometric password solution one face in. ... one face in, entering the ... ground-breaking and affordable multifactor-authentication biometric answer to the ... technology, provided in partnership with KeyLemon, one face ...
(Date:6/23/2015)... , June 23, 2015  Crossmatch™, ... and authentication solutions, today announced enhanced functionality of ... authentication solution.  The enhancements build on the ... the DigitalPersona Altus platform and provide expanded ... In today,s environment of increasing ...
(Date:6/17/2015)... , and HILDEN, Germany , June 17, ... ; Frankfurt Prime Standard: QIA) today launched new Investigator ® ... forensic laboratories in the United States . ... simultaneously analyze multiple key genomic markers (short tandem repeats or ... Quality Sensor to evaluate the quality of DNA in each ...
Breaking Biology News(10 mins):KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5
... In a new March of Dimes-funded study of pre-eclampsia, ... 5 percent of pregnancies, researchers have found results in ... treatment in humans. Yang Xia, M.D., Ph.D., and ... Biology; and Susan M. Ramin, M.D., Department of Obstetrics, ...
... life expectancy for patients with human immunodeficiency virus (HIV) ... late 1990s thanks to advancements in antiretroviral therapy, according ... (UAB) and Simon Fraser University in Vancouver, British Columbia. ... percent drop in AIDS deaths among 43,355 HIV-positive study ...
... New research published in the July issue of the ... elevated plasma DNA is a reliable marker of recurrent esophageal ... before clinical evidence of cancer recurrence in the majority of ... causes of cancer death worldwide, is usually diagnosed at a ...
Cached Biology News:New research on pre-eclampsia in mice may have important implications for humans 2Anti-HIV therapy boosts life expectancy more than 13 years 2Plasma DNA level is a reliable marker of recurrent esophageal cancer, study finds 2